chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Borrelia test negative, Condition aggravated, Electromyogram normal, Full blood count, Hemiparesis
Clinical narrative: Within 45 minutes of receiving the first Moderna vaccination on 3/6/21, Patient developed numbness and tingling to the left side of his face which continued for the subsequent five days which led him to present to the ER on 3/11/21. Patient seen with exam findings suggestive of recurrence of trigeminal neuritis which he experienced in the past. Patient denied fevers, chills, cough, SOB, chest pain, headache, changes in vision, neck pain, dizziness, changes in hearing, N/V, numbness or tingling in his arms or legs. Patient did have subtle diminished sensation of Trigeminal nerve (V1,V3), no decreased muscle tone or strength. Patient had no known tick bite. He was then  discharged with empiric antiviral and prednisone.  He then presented back to Hospital ER on 03/14/2021 with ongoing symptoms of left-sided facial paresthesias and new onset tingling and numbness to the entire left side of his face, left arm and left leg which began on 3/12/21.  He also reported some abnormality in his position sense.  He was endorsing subjective weakness on the left side of his body.  He denied fevers, chills, headache, cough, shortness of breath, or history of tick bite.  Vital signs were significant for blood pressure 136/83 with a heart rate of 84. His neurological examination was normal.  Complete metabolic panel was performed along with a CBC with differential.  Lyme screen negative.  Brain MRI normal findings.  He was without evidence of Bell's Palsy.  Case was reviewed with neurologist, who agreed with the workup.  Reassurance was provided and referral was placed to outpatient Neurology. The patient was established with Dr. and  had a visit on 3/17/21. Per patient, Dr. was  concerned about Guillain-Barre. He was then admitted to the hospital on 3/17/21 for further work-up including a lumbar puncture. LP 3/19/21 WNL, EMG negative. He was discharged on 3/19/21 with diagnosis of likely allergic reaction to vaccination. Symptoms of numbness/tingling and weakness to left arm has almost entirely resolved by 3/24. He continues with very mild residual paresthesias to left side of face, symptoms improving as of today 3/25
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Hypoaesthesia, Lumbar puncture normal, Magnetic resonance imaging head normal, Metabolic function test
Clinical narrative: Within 45 minutes of receiving the first Moderna vaccination on 3/6/21, Patient developed numbness and tingling to the left side of his face which continued for the subsequent five days which led him to present to the ER on 3/11/21. Patient seen with exam findings suggestive of recurrence of trigeminal neuritis which he experienced in the past. Patient denied fevers, chills, cough, SOB, chest pain, headache, changes in vision, neck pain, dizziness, changes in hearing, N/V, numbness or tingling in his arms or legs. Patient did have subtle diminished sensation of Trigeminal nerve (V1,V3), no decreased muscle tone or strength. Patient had no known tick bite. He was then  discharged with empiric antiviral and prednisone.  He then presented back to Hospital ER on 03/14/2021 with ongoing symptoms of left-sided facial paresthesias and new onset tingling and numbness to the entire left side of his face, left arm and left leg which began on 3/12/21.  He also reported some abnormality in his position sense.  He was endorsing subjective weakness on the left side of his body.  He denied fevers, chills, headache, cough, shortness of breath, or history of tick bite.  Vital signs were significant for blood pressure 136/83 with a heart rate of 84. His neurological examination was normal.  Complete metabolic panel was performed along with a CBC with differential.  Lyme screen negative.  Brain MRI normal findings.  He was without evidence of Bell's Palsy.  Case was reviewed with neurologist, who agreed with the workup.  Reassurance was provided and referral was placed to outpatient Neurology. The patient was established with Dr. and  had a visit on 3/17/21. Per patient, Dr. was  concerned about Guillain-Barre. He was then admitted to the hospital on 3/17/21 for further work-up including a lumbar puncture. LP 3/19/21 WNL, EMG negative. He was discharged on 3/19/21 with diagnosis of likely allergic reaction to vaccination. Symptoms of numbness/tingling and weakness to left arm has almost entirely resolved by 3/24. He continues with very mild residual paresthesias to left side of face, symptoms improving as of today 3/25
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neurological examination normal, Paraesthesia, Trigeminal nerve paresis, Trigeminal neuritis
Clinical narrative: Within 45 minutes of receiving the first Moderna vaccination on 3/6/21, Patient developed numbness and tingling to the left side of his face which continued for the subsequent five days which led him to present to the ER on 3/11/21. Patient seen with exam findings suggestive of recurrence of trigeminal neuritis which he experienced in the past. Patient denied fevers, chills, cough, SOB, chest pain, headache, changes in vision, neck pain, dizziness, changes in hearing, N/V, numbness or tingling in his arms or legs. Patient did have subtle diminished sensation of Trigeminal nerve (V1,V3), no decreased muscle tone or strength. Patient had no known tick bite. He was then  discharged with empiric antiviral and prednisone.  He then presented back to Hospital ER on 03/14/2021 with ongoing symptoms of left-sided facial paresthesias and new onset tingling and numbness to the entire left side of his face, left arm and left leg which began on 3/12/21.  He also reported some abnormality in his position sense.  He was endorsing subjective weakness on the left side of his body.  He denied fevers, chills, headache, cough, shortness of breath, or history of tick bite.  Vital signs were significant for blood pressure 136/83 with a heart rate of 84. His neurological examination was normal.  Complete metabolic panel was performed along with a CBC with differential.  Lyme screen negative.  Brain MRI normal findings.  He was without evidence of Bell's Palsy.  Case was reviewed with neurologist, who agreed with the workup.  Reassurance was provided and referral was placed to outpatient Neurology. The patient was established with Dr. and  had a visit on 3/17/21. Per patient, Dr. was  concerned about Guillain-Barre. He was then admitted to the hospital on 3/17/21 for further work-up including a lumbar puncture. LP 3/19/21 WNL, EMG negative. He was discharged on 3/19/21 with diagnosis of likely allergic reaction to vaccination. Symptoms of numbness/tingling and weakness to left arm has almost entirely resolved by 3/24. He continues with very mild residual paresthesias to left side of face, symptoms improving as of today 3/25
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Injection site pain, Neck pain, Pain, Pain in extremity, Pharyngeal swelling
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Disturbance in attention, Fatigue, Feeling abnormal, Headache
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Malaise, Muscular weakness, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Arrhythmia, Arthralgia, Blood test, Body temperature
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Brain oedema, Chills, Coma, Concussion, Dizziness
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Endocrine test, Headache, Hypoaesthesia, Injection site hypoaesthesia, Injection site paraesthesia
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Magnetic resonance imaging, Movement disorder, Muscular weakness, Musculoskeletal stiffness
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Myalgia, Pain, Palpitations, Paraesthesia, Photophobia
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Per patient (this examiner has not witnessed the SE): anaphylaxis a few minutes after the vaccine administration; she was nto transported to the ED or hospital. Patient reported extreme fatigue, malaise, achiness in the days post vaccination, Lt arm pain (vaccine site), Lt wrist 'limp', fever 'up to 104.8', HA, brain fogginess, inability to concentrate
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness unilateral, Retinal artery occlusion, Vision blurred, Vitreous floaters
Clinical narrative: Email received 3/15/21- Client reported fever, body itching, ankles hurting.  Reply email 3/19/21 to patient: "Thank you for contacting the us.  The reactions that you described are common side effects from the vaccine. If you are still experiencing, please use a pain relieving medication. " Email received from patient on 3/19/21- "To whom it may concern. I had a stroke in my eye. Spent three days in the hospital. Have lost majority of sight in left eye.  A Tylenol hardly seems adequate. Needless to say I will not be getting vaccine two. My life is forever changed. The arm was nothing compared to loosing your sight. "
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blindness unilateral, Pruritus, Pyrexia, Retinal artery occlusion
Clinical narrative: Email received 3/15/21- Client reported fever, body itching, ankles hurting.  Reply email 3/19/21 to patient: "Thank you for contacting the us.  The reactions that you described are common side effects from the vaccine. If you are still experiencing, please use a pain relieving medication. " Email received from patient on 3/19/21- "To whom it may concern. I had a stroke in my eye. Spent three days in the hospital. Have lost majority of sight in left eye.  A Tylenol hardly seems adequate. Needless to say I will not be getting vaccine two. My life is forever changed. The arm was nothing compared to loosing your sight. "
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fluorescence angiogram abnormal, Optical coherence tomography abnormal, Retinal artery occlusion, Visual impairment
Clinical narrative: Email received 3/15/21- Client reported fever, body itching, ankles hurting.  Reply email 3/19/21 to patient: "Thank you for contacting the us.  The reactions that you described are common side effects from the vaccine. If you are still experiencing, please use a pain relieving medication. " Email received from patient on 3/19/21- "To whom it may concern. I had a stroke in my eye. Spent three days in the hospital. Have lost majority of sight in left eye.  A Tylenol hardly seems adequate. Needless to say I will not be getting vaccine two. My life is forever changed. The arm was nothing compared to loosing your sight. "
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Computerised tomogram, Facial paralysis, Magnetic resonance imaging
Clinical narrative: developed Bells Palsy on the left side of my face; eye irritation; lack of blinking; stiffness in mouth and jaw; This is a spontaneous report from a contactable consumer. . A 37-years-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN 6205) via an unspecified route of administration in arm left on 06Mar2021 17:15 at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED MAGNESIUM CARBONATE]. The patient had no known allergies. The patient was not tested for COVID prior vaccination. The patient experienced facial paralysis, eye irritation, lack of blinking, stiffness in mouth and jaw. The patient underwent lab tests and procedures which included corneal reflex decreased, sars-cov-2 test: negative on 15Mar2021. Therapeutic measures were taken as a result of events with steroids. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Corneal reflex decreased, Eye irritation, Musculoskeletal stiffness, SARS-CoV-2 test
Clinical narrative: developed Bells Palsy on the left side of my face; eye irritation; lack of blinking; stiffness in mouth and jaw; This is a spontaneous report from a contactable consumer. . A 37-years-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN 6205) via an unspecified route of administration in arm left on 06Mar2021 17:15 at single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED MAGNESIUM CARBONATE]. The patient had no known allergies. The patient was not tested for COVID prior vaccination. The patient experienced facial paralysis, eye irritation, lack of blinking, stiffness in mouth and jaw. The patient underwent lab tests and procedures which included corneal reflex decreased, sars-cov-2 test: negative on 15Mar2021. Therapeutic measures were taken as a result of events with steroids. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Pt was hospitalized the day after her second COVID-19 Moderna vaccine .  Experienced slurred speech, confusion, fever, and incontinence.  Abomdinal pain beyond baseline.  Pt was hospitalized, seen at Dr. office for hospital follow up.  PCP's office submitting VAERS report.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Confusional state, Dysarthria, Incontinence, Pyrexia
Clinical narrative: Pt was hospitalized the day after her second COVID-19 Moderna vaccine .  Experienced slurred speech, confusion, fever, and incontinence.  Abomdinal pain beyond baseline.  Pt was hospitalized, seen at Dr. office for hospital follow up.  PCP's office submitting VAERS report.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Blood test, Brain natriuretic peptide increased, Chest X-ray abnormal, Condition aggravated
Clinical narrative: Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea exertional, Echocardiogram, Electrocardiogram, Fibrin D dimer increased
Clinical narrative: Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea exertional, Nucleic acid test, Pulmonary embolism, SARS-CoV-2 test
Clinical narrative: Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; Pulmonary emboli Symptoms (dyspnea on exertion) began about 07Mar2021; This is a spontaneous report from a contactable consumer. This 62-year-old male consumer (patient) reported that he received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 27Feb2021 16:45 (Batch/Lot Number: EN6201) as single dose for covid-19 immunization. Medical history included melanoma removed in 1991. The patient's concomitant medication was none. No other vaccine in four weeks. No other medications in two weeks. The patient experienced pulmonary emboli symptoms (dyspnea on exertion) began about 07Mar2021 (hospitalization in Mar2021 for 2 days, disability, life threatening) with outcome of not recovered. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests included Hologic nucleic acid amplification (Nasal Swab): negative on 10Mar2021, cobas RT-PCR (Nasal Swab): negative on 15Mar2021 (testing to identify diagnosis began about 10Mar2021, diagnosed 15Mar2021). Treatment for events included Heparin IV drip; discharged on apixaban (ELIQUIS). No COVID prior vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Nasal congestion, Rash, Swelling face
Clinical narrative: rash; hives; swollen face; congestion; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose, via an specified route administered in Arm Left on 14Feb2021 10:30 AM at single dose, second dose via an unspecified route of administration, administered in Arm Left on 07Mar2021 (Batch/Lot Number: ENG199) as SINGLE DOSE for covid-19 immunisation. Medical history included avn (left hip and both knees replaced), Known allergies: Bee stings, Cats. No covid prior vaccination. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT). No other vaccine in four weeks. The patient experienced Slight reaction from first shot: Rash, hives, swollen face, congestion. 10Mar2021 10:00 PM, the patient experienced same events after the second dose, resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient hospitalized for 1 day. The patient tested Covid post vaccination on 11Mar2021: Nasal Swab with Negative result. The outcome was recovering.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nasal congestion, Rash, SARS-CoV-2 test, Swelling face, Urticaria
Clinical narrative: rash; hives; swollen face; congestion; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose, via an specified route administered in Arm Left on 14Feb2021 10:30 AM at single dose, second dose via an unspecified route of administration, administered in Arm Left on 07Mar2021 (Batch/Lot Number: ENG199) as SINGLE DOSE for covid-19 immunisation. Medical history included avn (left hip and both knees replaced), Known allergies: Bee stings, Cats. No covid prior vaccination. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT). No other vaccine in four weeks. The patient experienced Slight reaction from first shot: Rash, hives, swollen face, congestion. 10Mar2021 10:00 PM, the patient experienced same events after the second dose, resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient hospitalized for 1 day. The patient tested Covid post vaccination on 11Mar2021: Nasal Swab with Negative result. The outcome was recovering.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Heart rate increased, Hypoaesthesia, Malaise, Nausea
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, Paraesthesia, Pyrexia, Vertigo
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Body temperature increased, Chest X-ray, Chills, Electrocardiogram
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema, Headache, Heart rate increased, Hypoaesthesia, Malaise
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Nausea, Pyrexia, Urinary tract infection, Viral test
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Heart rate, Heart rate increased
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hot flush, Pyrexia, Tremor, Urinary tract infection
Clinical narrative: 10 minutes after received shot, left arm went numb, then both arms turned blood red.  Two hours later had H/A, fever, chills, increased heart rate, 102.8, nauseous, caused UTI.  Wife had to help him get into the car due to feeling of illness.  No shortness of breath or difficulty breathing
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amaurosis fugax, Blindness unilateral, Computerised tomogram normal, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: Amaurosis fugax; This is a spontaneous report from a contactable consumer reporting for self. A 56-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 13Mar2021 11:15 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced amaurosis fugax (life threatening) on 15Mar2021 14:30 with outcome of unknown.   Information on the Lot/Batch number has been requested
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Optical coherence tomography normal, Retinal vascular thrombosis, Scan with contrast, Thrombosis
Clinical narrative: Amaurosis fugax; This is a spontaneous report from a contactable consumer reporting for self. A 56-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 13Mar2021 11:15 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced amaurosis fugax (life threatening) on 15Mar2021 14:30 with outcome of unknown.   Information on the Lot/Batch number has been requested
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amaurosis fugax
Clinical narrative: Amaurosis fugax; This is a spontaneous report from a contactable consumer reporting for self. A 56-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 13Mar2021 11:15 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced amaurosis fugax (life threatening) on 15Mar2021 14:30 with outcome of unknown.   Information on the Lot/Batch number has been requested
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eyelid sensory disorder, Hypoaesthesia eye, Hypoaesthesia oral
Clinical narrative: Patient states that evening that her tongue and lips felt heavy like after going to the dentist, by morning the right eye and ear were also effected. Has not seen a physician, keeping eye lubricated with drops. Too late at time of reporting to us for steroid treatment.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort
Clinical narrative: Patient states that evening that her tongue and lips felt heavy like after going to the dentist, by morning the right eye and ear were also effected. Has not seen a physician, keeping eye lubricated with drops. Too late at time of reporting to us for steroid treatment.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Chest X-ray abnormal, Chills, Computerised tomogram, Computerised tomogram abnormal
Clinical narrative: Hospitalization within 6 weeks after receiving vaccine
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Lung infiltration, Neutrophil count increased, Palpitations
Clinical narrative: Hospitalization within 6 weeks after receiving vaccine
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Platelet count decreased, Pulmonary oedema, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Hospitalization within 6 weeks after receiving vaccine
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Hospitalization within 6 weeks after receiving vaccine
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Hospitalization within 6 weeks after receiving vaccine
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Coma, Vomiting
Clinical narrative: Corporate office received notification that the patient passed away after having received the vaccine. The date of death is unknown.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Corporate office received notification that the patient passed away after having received the vaccine. The date of death is unknown.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Cerebral haemorrhage, Death, Vomiting
Clinical narrative: Corporate office received notification that the patient passed away after having received the vaccine. The date of death is unknown.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hypoaesthesia, Paraesthesia
Clinical narrative: Patient had vaccine at 6:10, she was observed in the waiting area for 30 minutes with no adverse reactions. Patient was walking out to her car and stated she had trouble breathing and felt tingling in her face, hands and feet. Patient was brought back into the clinic and evaluated at 6:50. Vital signs were within normal limits, patient did not have any difficulty breathing or noticeable swelling. No hives or rash was observed. Once seated in the clinic patient was given water and was able to calm down. Patient states her symptoms began to resolve but the numbness and tingling in her hands and feet persisted.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: CSF protein increased, CSF white blood cell count, Guillain-Barre syndrome, Muscular weakness, Paraesthesia
Clinical narrative: Guillian Barre Syndrome
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram head, Computerised tomogram spine, Guillain-Barre syndrome, Laboratory test, Lumbar puncture
Clinical narrative: Guillian Barre Syndrome
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral, Arteriogram carotid, Computerised tomogram head, Condition aggravated, Electromyogram
Clinical narrative: Guillian Barre Syndrome
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Muscular weakness
Clinical narrative: Guillian Barre Syndrome
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hyperhidrosis, Pain in extremity, Vomiting
Clinical narrative: Intractable nausea and vomiting, sweating and fatigue 48 hours post vaccine administration that lasted 1 day.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: Intractable nausea and vomiting, sweating and fatigue 48 hours post vaccine administration that lasted 1 day.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Electrocardiogram, Heart rate irregular
Clinical narrative: Pain in the left arm; Atrial fibrillation; Tired; This is a spontaneous report from a contactable consumer (patient).   A 66 years old female patient (weight: 107.95 kg, height: 165 cm) received the second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, in the left arm, on 04Mar2021, at 16:50, for COVID-19 immunisation. Relevant medical history included atrial fibrillation from Jan2016 and ongoing and cardiac ablation on an unspecified date, in Feb2020 (she had her 2nd ablation in Feb2020, since then she has had intermittent episodes of atrial fibrillation. She stated prior to the second vaccine she had been in normal sinus rhythm for 8 days). Patient stated that she had a sister who had an arrhythmia problem. The patient previously, on 10Feb2021, received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) in the left arm, at single dose, for COVID-19 immunisation. Patient stated that she had no problem with first dose. The patient received concomitant medications (unspecified). On 04Mar2021, at 21:00, the patient experienced atrial fibrillation and on 04Mar2021 she was tired. On 05Mar2021, she developed pain in the left arm. The patient recovered from pain in arm on 05Mar2021, from tiredness on 07Mar2021, while did not recover from atrial fibrillation.   The information on the lot number has been requested.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Fatigue, Pain in extremity, Sinus rhythm
Clinical narrative: Pain in the left arm; Atrial fibrillation; Tired; This is a spontaneous report from a contactable consumer (patient).   A 66 years old female patient (weight: 107.95 kg, height: 165 cm) received the second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, in the left arm, on 04Mar2021, at 16:50, for COVID-19 immunisation. Relevant medical history included atrial fibrillation from Jan2016 and ongoing and cardiac ablation on an unspecified date, in Feb2020 (she had her 2nd ablation in Feb2020, since then she has had intermittent episodes of atrial fibrillation. She stated prior to the second vaccine she had been in normal sinus rhythm for 8 days). Patient stated that she had a sister who had an arrhythmia problem. The patient previously, on 10Feb2021, received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) in the left arm, at single dose, for COVID-19 immunisation. Patient stated that she had no problem with first dose. The patient received concomitant medications (unspecified). On 04Mar2021, at 21:00, the patient experienced atrial fibrillation and on 04Mar2021 she was tired. On 05Mar2021, she developed pain in the left arm. The patient recovered from pain in arm on 05Mar2021, from tiredness on 07Mar2021, while did not recover from atrial fibrillation.   The information on the lot number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Electrocardiogram, Tachycardia
Clinical narrative: Developed racing heart feeling after vaccination. Had past history of anaphylaxis to sesame with similar symptom
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Developed racing heart feeling after vaccination. Had past history of anaphylaxis to sesame with similar symptom
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram abnormal, Blood test abnormal, Electroencephalogram abnormal, Encephalitis, Lumbar puncture abnormal
Clinical narrative: acute mental status changes & aphasia Started 3/18/2021  in the evening Pt became incoherent.  MRI /MRA/MRV EEG /LP done; RVP & coronavirus COVID PCR (-).  dx with COVID-19 in January, still has Antibodies Received COVID Vaccine 3/11/2021
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal
Clinical narrative: acute mental status changes & aphasia Started 3/18/2021  in the evening Pt became incoherent.  MRI /MRA/MRV EEG /LP done; RVP & coronavirus COVID PCR (-).  dx with COVID-19 in January, still has Antibodies Received COVID Vaccine 3/11/2021
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Aphasia, Electroencephalogram, Incoherent, Lumbar puncture
Clinical narrative: acute mental status changes & aphasia Started 3/18/2021  in the evening Pt became incoherent.  MRI /MRA/MRV EEG /LP done; RVP & coronavirus COVID PCR (-).  dx with COVID-19 in January, still has Antibodies Received COVID Vaccine 3/11/2021
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Mental status changes, Respiratory viral panel, SARS-CoV-2 antibody test positive, SARS-CoV-2 test negative
Clinical narrative: acute mental status changes & aphasia Started 3/18/2021  in the evening Pt became incoherent.  MRI /MRA/MRV EEG /LP done; RVP & coronavirus COVID PCR (-).  dx with COVID-19 in January, still has Antibodies Received COVID Vaccine 3/11/2021
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Venogram
Clinical narrative: acute mental status changes & aphasia Started 3/18/2021  in the evening Pt became incoherent.  MRI /MRA/MRV EEG /LP done; RVP & coronavirus COVID PCR (-).  dx with COVID-19 in January, still has Antibodies Received COVID Vaccine 3/11/2021
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Pain
Clinical narrative: Tightening in left pectoral muscle in the left arm pit which spread across my chest to the right pectoral within 15 minutes the tightness moved up into my neck. Within one hour it was gone. It was tightness not pain. Doctor at vaccine site recommended transporting me to the ER. Tests were administered, I was released with follow up recommendations. Next day some intermittent chest tightness-agreeing of pressure from both sides and weight on  breast bone. One time tightness in left chest during short walk.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Chest X-ray normal, Chest discomfort, Electrocardiogram normal, Muscle tightness
Clinical narrative: Tightening in left pectoral muscle in the left arm pit which spread across my chest to the right pectoral within 15 minutes the tightness moved up into my neck. Within one hour it was gone. It was tightness not pain. Doctor at vaccine site recommended transporting me to the ER. Tests were administered, I was released with follow up recommendations. Next day some intermittent chest tightness-agreeing of pressure from both sides and weight on  breast bone. One time tightness in left chest during short walk.
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Asthenia, Blood test, Cardiac monitoring, Chest X-ray
Clinical narrative: By Sunday I was so weak; I developed black diarrhea; Wednesday (day after vaccine)  I developed Gastric reflux which I never had before.; As the day  progressed I had severe abdominal pain that lasted throughout the day; Nausea set in late that evening; bleeding ulcer; This is a spontaneous report from a contactable consumer (patient). A 91-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Feb2021 13:00 at single dose for COVID-19 immunisation. Facility type vaccine was Nursing Home/Senior Living Facility (as reported). Medical history included high blood pressure, aortic valve replacement and stent placement, 1 kidney, cancer 12 years ago (2009). Patient was not pregnant, no known allergies. No covid prior vaccination. No Covid tested post vaccination. No other vaccine in four weeks. Other medications in two weeks was yes (blood pressure medication). Concomitant medications included unspecified blood pressure medication. Historical vaccine included the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in left arm on an unspecified date for COVID-19 immunisation.  Patient reported that on Wednesday (day after vaccine) (24Feb2021) she developed gastric reflux which she never had before (24Feb2021 08:00). As the day progressed she had severe abdominal pain that lasted throughout the day, also something she never had before. Nausea set in late that evening. Although Thursday was fairly stable, on Friday (26Feb2021) she developed black diarrhea that continued all day. By Sunday (28Feb2021) she was so weak that a Harrogate (senior living complex) nurse came and sent her to hospital via ambulance. After 4 days of blood tests, transfusions, a chest x-ray, heart monitor, endoscopy and colonoscopy etc. , the only diagnosis for the significant blood loss was a bleeding ulcer. This must have been developing on Wednesday (24Feb2021) when the severe pain began. After release from the 4 day (as reported) hospital stay, patient was sent to health clinic for 6 days to regain some strength. Since she never had ulcers, she firmly believed that everything was activated on Tuesday when she received the second Pfizer vaccine shot. Adverse events resulted in: Emergency room/department or urgent care, Hospitalization (as reported), Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). Number of days hospitalisation was 3 (as reported). Treatment included blood transfusions and intravenous (IV). The outcome of the events was recovered.  Information of lot/batch number has been requested.
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Colonoscopy, Diarrhoea, Endoscopy, Gastrooesophageal reflux disease, Nausea
Clinical narrative: By Sunday I was so weak; I developed black diarrhea; Wednesday (day after vaccine)  I developed Gastric reflux which I never had before.; As the day  progressed I had severe abdominal pain that lasted throughout the day; Nausea set in late that evening; bleeding ulcer; This is a spontaneous report from a contactable consumer (patient). A 91-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Feb2021 13:00 at single dose for COVID-19 immunisation. Facility type vaccine was Nursing Home/Senior Living Facility (as reported). Medical history included high blood pressure, aortic valve replacement and stent placement, 1 kidney, cancer 12 years ago (2009). Patient was not pregnant, no known allergies. No covid prior vaccination. No Covid tested post vaccination. No other vaccine in four weeks. Other medications in two weeks was yes (blood pressure medication). Concomitant medications included unspecified blood pressure medication. Historical vaccine included the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in left arm on an unspecified date for COVID-19 immunisation.  Patient reported that on Wednesday (day after vaccine) (24Feb2021) she developed gastric reflux which she never had before (24Feb2021 08:00). As the day progressed she had severe abdominal pain that lasted throughout the day, also something she never had before. Nausea set in late that evening. Although Thursday was fairly stable, on Friday (26Feb2021) she developed black diarrhea that continued all day. By Sunday (28Feb2021) she was so weak that a Harrogate (senior living complex) nurse came and sent her to hospital via ambulance. After 4 days of blood tests, transfusions, a chest x-ray, heart monitor, endoscopy and colonoscopy etc. , the only diagnosis for the significant blood loss was a bleeding ulcer. This must have been developing on Wednesday (24Feb2021) when the severe pain began. After release from the 4 day (as reported) hospital stay, patient was sent to health clinic for 6 days to regain some strength. Since she never had ulcers, she firmly believed that everything was activated on Tuesday when she received the second Pfizer vaccine shot. Adverse events resulted in: Emergency room/department or urgent care, Hospitalization (as reported), Prolongation of existing hospitalization (vaccine received during existing hospitalization), Life threatening illness (immediate risk of death from the event). Number of days hospitalisation was 3 (as reported). Treatment included blood transfusions and intravenous (IV). The outcome of the events was recovered.  Information of lot/batch number has been requested.